|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:P02743 |
serum amyloid P-component (human)
|
hAPCS
|
"A serum amyloid P-component that is encoded in the genome of human." [PRO:DNx, UniProtKB:P02743]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000046352 |
serum amyloid P-component, signal peptide removed form (human)
|
hAPCS/SigPep-
|
"A serum amyloid P-component (human) that has had the signal peptide removed. UniProtKB:P02743, 20-223." [PRO:DNx, Reactome:R-HSA-976737]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052725 |
serum amyloid P-component N-glycosylated 1 (human)
|
hAPCS/NGlyco:1
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G07995VK. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G07995VK." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052726 |
serum amyloid P-component N-glycosylated 2 (human)
|
hAPCS/NGlyco:2
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G14047PA. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G14047PA." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052727 |
serum amyloid P-component N-glycosylated 3 (human)
|
hAPCS/NGlyco:3
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G36191CD." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052728 |
serum amyloid P-component N-glycosylated 4 (human)
|
hAPCS/NGlyco:4
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G45560HM. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G45560HM." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052729 |
serum amyloid P-component N-glycosylated 5 (human)
|
hAPCS/NGlyco:5
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G51793MY. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G51793MY." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052730 |
serum amyloid P-component N-glycosylated 6 (human)
|
hAPCS/NGlyco:6
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G53276NK. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G53276NK." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052731 |
serum amyloid P-component N-glycosylated 7 (human)
|
hAPCS/NGlyco:7
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G75850OP. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G75850OP." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052732 |
serum amyloid P-component N-glycosylated 8 (human)
|
hAPCS/NGlyco:8
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G77252PU. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G77252PU." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052733 |
serum amyloid P-component N-glycosylated 9 (human)
|
hAPCS/NGlyco:9
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G84467IZ." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052734 |
serum amyloid P-component N-glycosylated 10 (human)
|
hAPCS/NGlyco:10
|
"A serum amyloid P-component (human) that has been N-glycosylated at the residue equivalent to Asn-51 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan structure is represented by GlyTouCan:G91365ZQ. Example: UniProtKB:P02743-1, Asn-51, MOD:00160~GNO:G91365ZQ." [GlyGen:P02743-1, PMID:8202534, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000052735 |
serum amyloid P-component O-glycosylated 1 (human)
|
hAPCS/OGlyco:1
|
"A serum amyloid P-component (human) that has been O-glycosylated at the residue equivalent to Thr-195 of the amino acid sequence represented by UniProtKB:P02743-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02743-1, Thr-195, MOD:00005~GNO:G43417UB." [GlyGen:P02743-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
